Core Viewpoint - Morgan Stanley analyst Jack Lin initiated a "Sell" rating for Hutchison China MediTech (HCM.US) with a target price of $13.75, leading to a pre-market drop of 2.58% to $16.60 [1] Company Summary - The closing price on September 19 was $17.04, with a decrease of 2.35% [1] - The pre-market price on September 22 was $16.60, reflecting a drop of $0.44 [1] - The stock reached a high of $17.29 and a low of $17.02 during the trading session [1] - The total market capitalization of the company is approximately $2.972 billion [1] - The price-to-earnings (P/E) ratio is 85.20, and the price-to-book (P/B) ratio is 2.418 [1] - The stock has a 52-week high of $21.50 and a low of $11.505 [1] - The average trading price was $17.108, with a trading volume of 31,200 shares [1]
美股异动｜和黄医药盘前跌逾2% 大摩首予“卖出”评级